Prosecution Insights
Last updated: November 18, 2026

Five Prime Therapeutics Inc.

Technology area: Biotechnology & Pharmaceuticals

3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Analysis

Five Prime Therapeutics Inc. has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 distinct examiners and 2 distinct art units, indicating separate examination assignments within the portfolio.

ALSOMAIRY, SARAH ABDOALATIF is the busiest examiner, with 1 pending matter. Counsel can use separate response plans for the two matters while maintaining consistent portfolio terminology.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
1
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
3
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (33%)
§102 only1 (33%)
Double-patenting + other1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ALSOMAIRY, SARAH ABDOALATIF 1 58.2% +31.0%
DENT, ALANA HARRIS 1 44.1% +32.2%
SKOKO III, JOHN JOSEPH 1 52.1% +56.1%

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17282589 Anti-FGFR2 Antibody Formulations SKOKO III, JOHN JOSEPH 33d
18741328 B7-H4 ANTIBODY DOSING REGIMENS ALSOMAIRY, SARAH ABDOALATIF —
17773800 CD80 EXTRACELLULAR DOMAIN FC FUSION PROTEIN REGIMENS DENT, ALANA HARRIS —

Top Art Units

Art UnitApps
1643 2
1646 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18741328 B7-H4 ANTIBODY DOSING REGIMENS ALSOMAIRY, SARAH ABDOALATIF 1646 §102Other Non-Final OA — Pending Jun 12, 2024
17773800 CD80 EXTRACELLULAR DOMAIN FC FUSION PROTEIN REGIMENS DENT, ALANA HARRIS 1643 §103Other Final Rejection — Pending May 02, 2022
17282589 Anti-FGFR2 Antibody Formulations SKOKO III, JOHN JOSEPH 1643 §103DP Final Rejection 33d Pending Apr 02, 2021

Managing Five Prime Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Five Prime Therapeutics Inc. have?

Five Prime Therapeutics Inc. has 3 pending office actions as of November 2026, spread across 2 art units and 3 examiners.

Which USPTO examiner handles the most Five Prime Therapeutics Inc. applications?

Sarah Abdoalatif Alsomairy has the most, with 1 of Five Prime Therapeutics Inc.'s pending office actions.

What technology area are Five Prime Therapeutics Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month